Now Legal Immunity for Swine flu Vaccine Makers
By F. William Engdahl
The US Secretary of Health and Human Services, Kathleen Sebelius, has just signed a decree granting vaccine makers total legal immunity from any lawsuits that result from any new “Swine Flu” vaccine. Moreover, the $7 billion US Government fast-track program to rush vaccines onto the market in time for the Autumn flu season is being done without even normal safety testing. Is there another agenda at work in the official WHO hysteria campaign to declare so-called H1N1 virus—which has yet to be rigorously scientifically isolated, characterized and photographed with an electron microscope—the scientifically accepted procedure—a global “pandemic” threat?
The current official panic campaign over alleged Swine Flu danger is rapidly taking on the dimensions of a George Orwell science fiction novel. The document signed by Sebelius grants immunity to those making a swine flu vaccine, under the provisions of a 2006 law for public health emergencies.
Not so sage SAGE
That is once the WHO in Geneva, on recommendation of the WHO’s Strategic Advisory Group on Immunizations, declared H1N1 to be Phase 6 or Pandemic, automatic emergency health response programs could be activated even in countries such as Germany where reported outbreaks of even “suspected” H1N1 can be counted to date on the fingers of slightly more than one hand.
The WHO’s SAGE is also worth scrutiny. Its Chairman since 2005 has been the UK Director of Immunization at the British Department of Health, Dr David Salisbury. In the 1980’s Salisbury reportedly drew major fire for backing a massive vaccination of children with a multiple MMR vaccine manufactured by the predecessor company of GlaxoSmithKline. That vaccine was pulled off the market in Japan after significant numbers of children developed adverse reactions to the vaccine and the Japanese government was forced to pay significant compensation to the victims. In Sweden the MMR vaccine of GlaxoSmithKline was removed after scientists linked it to outbreaks of Crohn’s disease. Apparently that had little impact on WHO SAGE chairman Salisbury.
According to one independent UK investigator, Alan Golding, who obtained Freedom of Information documents on the case, in “1986 Trivirix, an MMR compound containing the Mumps Urabe strain AM-9, was introduced in Canada to replace MMR I. Concerns regarding the introduction of MMR in the UK are recorded in the minutes of the Joint Working Party of the British Paediatric Association and the Joint Committee on Vaccination and Immunization (JCVI) Liaison Group on June 26th of that year. Such concerns were soon to prove well grounded, as reports began to come in of an increased incidence of aseptic meningitis in vaccinated individuals. Ultimately, all MMR vaccines containing the Urabe strain of mumps were withdrawn in Canada in early 1988. This was before Urabe containing vaccines were licenced by the Department of Health for use in the UK…”
The report adds, “Smith-Kline—French, the pharmaceutical company who became Smith-Kline-Beecham and were involved in UK manufacture at that time, were concerned about these safety issues and were reluctant to obtain a UK license for their Urabe-containing vaccines. As a result of their ‘concern’ that children might be seriously damaged by one of their products, they requested that the UK government indemnify them against possible legal action that might be taken as a result of ‘losses’ associated with the vaccine, which by then was known to carry significant risk to health. The UK government, advised by Professor Salisbury and representatives from the Department of Health, in it’s enthusiasm to get a cheap MMR onto the market, agreed to this request.”
Today the same Dr Salisbury is advocating global proliferation of untested H1N1 vaccines, also manufactured by the same firm, now called GlaxoSmithKline.
The last phoney Swine Flu Disaster
The last time the US Government faced a new swine flu virus was in 1976. Thousands filed claims contending they suffered side effects from the shots. This time, the government has taken steps to prevent any possible legal remedy should thousands of US citizens suffer severe complications as a result of being given untested vaccines.
In 1976 President Gerald Ford, facing a difficult re-election campaign, was advised by the head of the CDC, David Sencer, to launch a mass national vaccination. As today with H1N1 Swine Flu, Sencer also used the scare of the alleged 1918 flu pandemic. Notably, some scientific researchers maintain that the deaths during the flu wave of 1918-1919, in the aftermath of the ghastly First World War, came not from any virus but from the governmental campaigns of mass vaccination against “Spanish Flu.” Interestingly, the Rockefeller University and Foundation was in the middle of that event as well.
Cases of what was then called swine flu were found in soldiers at Fort Dix, N.J. in 1976, including one death. That death, whose true cause is in dispute as the soldier, sick with influenza was put on a forced march despite and fell dead, was used by Sencer to convince Ford to launch one of the most infamous public health fiascos in US history, forcing Sencer’s resignation as CDC head. Federal officials vaccinated 40 million Americans during a national campaign. A pandemic never materialized, but thousands who got the shots filed injury claims, as they contracted a paralyzing condition called Guillain-Barre Syndrome or other side effects. At least 25 people died after receiving the vaccine died and 500 developed Guillain-Barre syndrome, an inflammation of the nervous system which can cause paralysis and be fatal. The US Government was forced to pay damages after vaccination victims made it a national scandal. In the end the 1976 Swine Flu vaccine proved far worse than the disease.
Sencer was fired in 1977 for the fiasco but by then the damage had already been done.
No Safety Test? Don’t worry, be happy…
The story gets worse. Now that the Obama Administration has signed a document of immunity from legal prosecution, the FDA in the United States and UK health authorities have decided to let Big Pharma put vaccine products onto the market before any tests of the possible harmful side effects of the vaccines are even known.
The first doses of swine flu vaccine will be given to the public before full data on its safety and effectiveness become available. The untested “pandemic” vaccines will be spread over two doses in a higher quantity, and one brand reportedly will contain a chemical additive, an adjuvant, to make it “go further,” dramatically potentially increasing the risk of side-effects.
Children will be among those first in line for the shots and may get the vaccine more than a month before trial results are received.
In the UK the government’s National Health Service, NHS, has been ordered to plan for a worst-case scenario in which swine flu might cause 65,000 deaths over the coming winter, including several thousand deaths among children.
The British Government has placed advance orders for 132 million doses of vaccine with two manufacturers, GlaxoSmithKline and Baxter, who have licensed “in advance” three “core” vaccines in preparation for a pandemic, conveniently enough even though we are told by WHO and epidemiologists that we cannot prepare in advance for what could be a more ominous mutation of the currently very mild H1N1 problem.
Curiously enough, a full year before any reported case of the current alleged H1N1, the major pharmaceutical company, Baxter, filed for a patent for H1N1 vaccine: Baxter Vaccine Patent Application US 2009/0060950 A1. Their application states, “the composition or vaccine comprises more than one antigen…..such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes.”
The application further states, “Suitable adjuvants can be selected from mineral gels, aluminium hydroxide, surface active substances, lysolecithin, pluronic polyols, polyanions or oil emulsions such as water in oil or oil in water, or a combination thereof. Of course the selection of the adjuvant depends on the intended use. E.g. toxicity may depend on the destined subject organism and can vary from no toxicity to high toxicity.”